ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $790,000 | +24.4% | 200,000 | 0.0% | 0.02% | -5.9% |
| Q3 2019 | $635,000 | -75.9% | 200,000 | -23.5% | 0.02% | -66.0% |
| Q3 2017 | $2,640,000 | -74.0% | 261,400 | +161.4% | 0.05% | -90.2% |
| Q2 2017 | $10,164,000 | +101.2% | 100,000 | -60.2% | 0.51% | +77.4% |
| Q1 2017 | $5,051,000 | -61.5% | 251,328 | -70.2% | 0.29% | -69.2% |
| Q4 2016 | $13,128,000 | +15.8% | 842,128 | -3.1% | 0.93% | +27.6% |
| Q3 2016 | $11,339,000 | +94.9% | 868,897 | +2.3% | 0.73% | +81.6% |
| Q2 2016 | $5,818,000 | -27.5% | 849,350 | 0.0% | 0.40% | -42.8% |
| Q1 2016 | $8,026,000 | +42.7% | 849,350 | +52.1% | 0.70% | +69.2% |
| Q4 2015 | $5,623,000 | -66.1% | 558,446 | -51.8% | 0.42% | -37.2% |
| Q3 2015 | $16,580,000 | – | 1,158,700 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |